These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7716841)

  • 1. Distinguishing prognostic and treatment-predictive information for localized prostate cancer.
    Steineck G; Adolfsson J; Scher HI; Whitmore WF
    Urology; 1995 Apr; 45(4):610-5. PubMed ID: 7716841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and treatment-predictive factors-is there a difference?
    Adolfsson J; Steineck G
    Prostate Cancer Prostatic Dis; 2000 Dec; 3(4):265-268. PubMed ID: 12497075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic markers in clinically localized prostate cancer.
    Pettaway CA
    Tech Urol; 1998 Mar; 4(1):35-42. PubMed ID: 9568775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in prostate cancer.
    Stattin P
    Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive modeling in prostate cancer. Conclusions and reflections.
    Denis LJ; Gospodarowicz MK
    Cancer; 2009 Jul; 115(13 Suppl):3160-2. PubMed ID: 19544535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A
    BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up.
    Vicini FA; Martinez A; Hanks G; Hanlon A; Miles B; Kernan K; Beyers D; Ragde H; Forman J; Fontanesi J; Kestin L; Kovacs G; Denis L; Slawin K; Scardino P
    Cancer; 2002 Nov; 95(10):2126-35. PubMed ID: 12412166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
    Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors of prostatic cancer].
    Okada Y; Shichiri Y; Ogawa O; Yoshida O
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1999-2005. PubMed ID: 7487134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy.
    Ross RW; Manola J; Hennessy K; Galsky M; Scher H; Small E; Kelly WK; Kantoff PW
    Clin Cancer Res; 2005 Jul; 11(14):5195-8. PubMed ID: 16033836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors in localized prostate cancer: implications for radiotherapy and clinical trial design.
    Pisansky TM; Davis BJ
    Semin Urol Oncol; 2000 May; 18(2):93-107. PubMed ID: 10875449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
    Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
    J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice.
    Dowling AJ; Czaykowski PM; Krahn MD; Moore MJ; Tannock IF
    J Urol; 2000 May; 163(5):1481-5. PubMed ID: 10751862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.
    Hoffman RM; Barry MJ; Stanford JL; Hamilton AS; Hunt WC; Collins MM
    Am J Med; 2006 May; 119(5):418-25. PubMed ID: 16651054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.
    Casella R; Bubendorf L; Sauter G; Moch H; Mihatsch MJ; Gasser TC
    J Urol; 1998 Aug; 160(2):406-10. PubMed ID: 9679888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of men with clinically localized prostate cancer who deferred definitive therapy.
    Patel MI; DeConcini DT; Lopez-Corona E; Ohori M; Wheeler T; Scardino PT
    J Urol; 2004 Apr; 171(4):1520-4. PubMed ID: 15017211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.